The clinical guideline emphasizes the importance of timing and skill in performing amniocentesis and chorionic villus sampling, with specific gestational age recommendations to minimize risks. Women should be informed of the slight risk of miscarriage associated with these procedures and receive individualized counseling. Training and maintaining good practice are crucial to reduce procedure-related risks, and support should be provided throughout the decision-making process and aftercare. Screening for blood-borne viruses before invasive testing is essential, with recommendations for optimizing antiretroviral treatment for HIV-positive women. Limited data are available for mother-to-child transmission of Hepatitis B and C following these procedures.